These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3576165)

  • 1. [Monitoring of heparin therapy using thrombin time and activated partial thromboplastin time--a comparison].
    Osterwalder J
    Schweiz Med Wochenschr; 1987 Apr; 117(14):539-40. PubMed ID: 3576165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M; Fey MF; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of heparin therapy with activated recalcification time].
    Lutze G; Schlote A; Urbahn H
    Z Gesamte Inn Med; 1981 Feb; 36(4):102-6. PubMed ID: 7222858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin time dilution test: a simple method for the control of heparin therapy.
    Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C
    Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is the activated partial thromboplastin time suitable for monitoring of thrombosis therapy with high-dose standard heparin?].
    Hürzeler C; von Felten A
    Schweiz Med Wochenschr; 1994 Apr; 124(17):712-9. PubMed ID: 8202668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation parameters in high-dosage intravenous heparin therapy].
    Hafner G
    Dtsch Med Wochenschr; 1993 Aug; 118(31):1131-2. PubMed ID: 8344170
    [No Abstract]   [Full Text] [Related]  

  • 11. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the intrinsic pathway of coagulation during heparin therapy.
    Hoffmann JJ
    Thromb Haemost; 1985 Feb; 53(1):161. PubMed ID: 3992518
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
    van den Besselaar AM; Meeuwisse-Braun J; Jansen-Grüter R; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):226-31. PubMed ID: 3603414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin therapy and its monitoring].
    Camici M; Evangelisti L
    Clin Ter; 1991 Feb; 136(4):279-82. PubMed ID: 1827391
    [No Abstract]   [Full Text] [Related]  

  • 19. Activated partial thromboplastin time performed on capillary blood.
    Boumerfeg M; Aurousseau MH; Le Roux G; Lortholary P
    Nouv Rev Fr Hematol (1978); 1989; 31(5):359-61. PubMed ID: 2587206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin assays and bleeding complications in treatment of deep venous thrombosis with particular reference to retroperitoneal bleeding.
    Holm HA; Abildgaard U; Kalvenes S
    Thromb Haemost; 1985 Apr; 53(2):278-81. PubMed ID: 4024037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.